ATI Physical Therapy Revenue 2020-2023 | ATIP
ATI Physical Therapy revenue from 2020 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| ATI Physical Therapy Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $699 |
| 2022 | $636 |
| 2021 | $628 |
| 2020 | $592 |
| 2019 | $785 |
| ATI Physical Therapy Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | $182 |
| 2023-09-30 | $177 |
| 2023-06-30 | $172 |
| 2023-03-31 | $167 |
| 2022-12-31 | $162 |
| 2022-09-30 | $157 |
| 2022-06-30 | $163 |
| 2022-03-31 | $154 |
| 2021-12-31 | $156 |
| 2021-09-30 | $159 |
| 2021-06-30 | $164 |
| 2021-03-31 | $149 |
| 2020-12-31 | |
| 2020-09-30 | $149 |
| 2020-06-30 | $108 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.017B | $0.699B |
| ATI Physical Therapy Inc. is a portfolio company of Advent International as well as provider of outpatient physical therapy services. ATI Physical Therapy Inc., formerly known as Fortress Value Acquisition Corp. II, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.509B | 9.99 |
| Quest Diagnostics (DGX) | United States | $15.276B | 15.79 |
| DaVita (DVA) | United States | $11.641B | 15.84 |
| Chemed (CHE) | United States | $9.342B | 29.00 |
| Encompass Health (EHC) | United States | $8.292B | 21.34 |
| Elanco Animal Health (ELAN) | United States | $6.576B | 14.95 |
| Option Care Health (OPCH) | United States | $5.202B | 19.69 |
| RadNet (RDNT) | United States | $3.333B | 97.34 |
| Amedisys (AMED) | United States | $2.974B | 21.08 |
| LifeStance Health (LFST) | United States | $2.358B | 0.00 |
| Astrana Health (ASTH) | United States | $2.051B | 25.88 |
| U.S Physical Therapy (USPH) | United States | $1.562B | 40.49 |
| Addus HomeCare (ADUS) | United States | $1.550B | 23.76 |
| Pennant (PNTG) | United States | $0.622B | 36.33 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.444B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.313B | 0.00 |
| Daxor (DXR) | United States | $0.047B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| Ontrak (OTRK) | United States | $0.009B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |